Due to the relevance of Carboplatin or Cisplatin combined with Paclitaxel as part of the standard chemotherapy employed to treat ovarian cancer patients, we also determined the sensitivity of OVCAR-8 cells expressing truncated DAPK1 to Cisplatin. The gene discussed is DAPK1; the disease is ovarian carcinoma.